Pyari Bose Selected Research

vofopitant

1/2021

Therapeutic targeting of nitroglycerin-mediated trigeminovascular neuronal hypersensitivity predicts clinical outcomes of migraine abortives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pyari Bose Research Topics

Disease

4	Migraine Disorders (Migraine) 05/2021 - 01/2018
2	Hyperalgesia 01/2021 - 01/2019
2	Hypersensitivity (Allergy) 01/2021 - 01/2019
1	Headache (Headaches) 01/2021

Drug/Important Bio-Agent (IBA)

2	Nitroglycerin (Dynamite)FDA LinkGeneric 05/2021 - 01/2021
2	Tryptamines (Triptans)IBA 01/2021 - 01/2019
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2021
1	vofopitantIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2019
1	Biological ProductsIBA 01/2019

Therapy/Procedure

1	Therapeutics 01/2018